Health PR

Makovsky + Company’s health public relations engagements often involve sensitive work in highly specialized clinical areas such as cardiology, endocrinology, genomics, oncology and pediatrics – fields that require in-depth knowledge of state and Federal reimbursement policies, clinical thought leadership and advocacy relations, in addition to strong editorial and media skills.

Our approach works. While many clients change agencies in search of better service and new ideas, Makovsky’s healthcare practice maintains an unusually high retention rate.

Case Studies

Making Waves in a Crowded Market

Overcoming the Dark Side of a Drug

Building Support for an Orphan Drug

Putting Patient Safety First

Fundraising Focus

Makovsky on Industry Issues

possibility of biotech drugs facing competition from follow-on drugs has become caught in the legislative traffic-jam.

PRWeek asked public affairs and healthcare PR pros to grade communications efforts at Thursday's healthcare summit.

Two Makovsky Health Practice leaders will be featured presenters at two industry conferences on biosimilars.

Makovsky's Health Practice leaders will be featured presenters at two industry conferences on biosimilars.

Makovsky has expanded its healthcare practice, adding digital and visual communications capabilities.

Evangelists

Executive Vice President
212.508.9672
Senior Vice President
212.508.9642

Practice Poll

Will the next FDA Commissioner be most likely to focus on: